Wayne Markowitz
Known title: CVP, JAPACCIK: 0001991414
Associated companies
Transaction History
| EW | ▼ Sell | Tax Withholding | 568 | $48K | 9/14/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 355 | $31K | 9/11/2026 | View on chart |
| EW | ▼ Sell | Open Market | 1,240 | $113K | 8/26/2026 | View on chart |
| EW | ▼ Sell | Open Market | 146 | $13K | 7/30/2026 | View on chart |
| EW | ▼ Sell | Open Market | 9,628 | $819K | 7/28/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 9,628 | $713K | 7/28/2026 | View on chart |
| EW | ▼ Sell | Open Market | 593 | $47K | 5/11/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 226 | $19K | 5/8/2026 | View on chart |
| EW | ▲ Buy | Grant | 5,200 | $0 | 5/7/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 264 | $22K | 5/7/2026 | View on chart |
| EW | ▼ Sell | Open Market | 583 | $50K | 12/8/2025 | View on chart |
| EW | ▼ Sell | Tax Withholding | 650 | $50K | 9/14/2025 | View on chart |
| EW | ▲ Buy | Grant | 6,410 | $0 | 9/11/2025 | View on chart |
| EW | ▲ Buy | Grant | 3,350 | $0 | 5/8/2025 | View on chart |
| EW | ▼ Sell | Open Market | 268 | $20K | 5/7/2025 | View on chart |
| EW | ▼ Sell | Tax Withholding | 300 | $22K | 5/7/2025 | View on chart |
| EW | ▼ Sell | Open Market | 583 | $43K | 12/6/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 648 | $44K | 9/14/2024 | View on chart |
| EW | ▲ Buy | Grant | 3,350 | $0 | 5/7/2024 | View on chart |
| EW | ▲ Buy | Grant | 7,262 | $0 | 9/14/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
EW: FDA Flags High-Risk Device Recall After Patient Death
The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.
EW: FDA Flags High-Risk Device Recall After Patient Death. The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.